Clinical Importance of Treating Iron Overload in Sickle Cell Disease

NCT00981370 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped 1 consented patient never started on study drug, lost to follow up

Conditions

Anemia, Sickle Cell
Transfusion Hemosiderosis

Interventions

DRUG: deferasirox

Sponsor

Children's Hospital Los Angeles

Collaborators

[object Object]